|
A Division of PTM Healthcare Marketing, Inc. | |
Medical Device News Magazine, is a digital publication founded in 2008 and located in the United States. Our publication is one of the most trusted sources of information for the medical device and biotech industries, providing timely and accurate updates to professionals and enthusiasts alike. With 24/7/365 accessibility, our magazine is the perfect solution for anyone looking for a fast, easy read on the latest industry news. Stay informed with Medical Device News Magazine – your one-stop source for biotech and medical device industry updates. A Fast 1, 2, 3 easy read!
| |
|
August 1, 2023
"We are pleased to have safely implanted the first patient in China with the TaurusTrio™ TAVR System," said Dr. Yi Zhang, Chief Executive Officer of Peija Medical. "The trial reinforces our goals of improving care in the field of cardiology and expanding TAVR systems within China. We are looking forward to our continued partnership with American company, JenaValve and presenting further data from the clinical trial at a future date."
| | | |
August 1, 2023
The TRIA polymer surical mitral heart valve is designed specifically to accommodate the anatomy and pressures of the mitral position. It combines the company’s proprietary polymer – LifePolymer™ – with an innovative valve design intended to resist calcification, withstand stresses and strains without failure, and restore patient quality of life without lifelong use of anticoagulants.
August 1, 2023
Although NordPass looks at the change in internet users' password habits year-round, this year, the company specifically investigated passwords that employees of the world’s biggest companies from 31 countries use to secure business accounts. The researchers compiled 20 industry-specific passwords lists.
| |
August 1, 2023
North Shore University Hospital tied for No. 1 in New York as eight hospitals in the system are among the top in the state, and dozens of specialties were named the best in the nation.
| |
|
August 1, 2023
Dr Andrew Southan, Chief Executive of Metrion Biosciences, said: “The launch of our GLP hERG screening capability adds further depth to our ion channel drug discovery services and complements our existing cardiac safety service portfolio. Our team is pleased to be able to offer GLP quality services to new and existing clients globally as we continue to develop Metrion as a leading ion channel focused CRO.”
| |
August 1, 2023
Pintuition is a surgical marker navigation system that provides surgeons with both distance and direction to non-palpable tumors with exceptional accuracy. Patients benefit from enhanced diagnostic accuracy, reduced procedure times, and improved treatment planning.
| |
|
August 1, 2023
BRIUMVI is the first and only anti-CD20 monoclonal antibody approved in the United States (US) and European Union (EU) for adult patients with relapsing forms of multiple sclerosis (RMS) that can be administered in a one-hour infusion, twice a year, following the starting dose. Neuraxpharm is backed by funds advised by the global private equity firm, Permira.
August 1, 2023
LYT-300, an oral prodrug of allopregnanolone, is PureTech’s wholly-owned therapeutic candidate for the potential treatment of anxiety disorders, postpartum depression, FXTAS and other neurological and neuropsychiatric indications. LYT-300 was developed using PureTech’s GlyphTM platform, which harnesses the body’s natural lipid absorption and transport process to enable the oral administration of certain therapeutics that otherwise cannot be administered orally.
August 1, 2023
Kurt P. Spindler, MD, FAAOS, AAOS PROMs workgroup chair. "The new AAOS PROMs user guide, scoring tool and other high-quality resources distill knowledge and expertise from a broad range of stakeholders and orthopaedic experts to provide a set of best practices to facilitate an organization's ability to implement and utilize PROMs."
| |
August 1, 2023
Brian Zumbolo is new President at US facility.
| |
|
August 1, 2023
ALTB-268 was well tolerated with no serious adverse events across all subject cohorts. In addition, ALTB-268 demonstrated substantially greater biological activity than first ICE molecule, ALTB-168, enabling subcutaneous administration.
August 1, 2023
The study utilized data from the first linkage of prostate cancer cases reported by central cancer registries participating in the Surveillance, Epidemiology, and End Results (SEER) Program, with Decipher test results. SEER is a population-based cancer registry supported by the National Cancer Institute (NCI). The findings appear online in JNCI Cancer Spectrum.
August 1, 2023
This novel technology is designed for patients with aortic valvular disease. Aortic regurgitation is a common condition that can lead to heart failure. The J-Valve™ transcatheter aortic valve replacement procedure is performed through a minimally invasive transvascular approach, without the need for open-heart procedure or extracorporeal circulation.
| |
August 2, 2023
“Our technology’s capability to monitor a patient's function in office and then at the patient’s home over a period of time is a catalyst for change in healthcare – signifying cost savings for patients and payers,” says Carter Brown, CEO, BioMech Health. “Because BioMech Lab can set baselines in the office and then monitor a patient’s progress at home, physicians can actively ascertain patient progress without having to incur the inconvenience and costs of an office visit.”
August 2, 2023
“We’re delighted to have Dr. Gregg L Semenza speak on this very important topic in medicine. He is an outstanding example of a physician scientist whose work has set the bedrock for numerous clinical innovations,” said MediPines CEO, Steve Lee, who co-invented non-invasive pulmonary gas exchange monitoring technology, AGM100, with Dr. West.
| |
August 3, 2023
This remarkable ultrafilter membrane for dialysis represents a significant advancement, particularly in the field of dialyzers, the blood filtration device used in hemodialysis machines to remove toxins, where it promises improved dialysis performance and enhanced ultrafiltration flux.
| |
|
August 3, 2023
"From the outset, our vision for Evie has been to develop a consumer wearable that is beautiful, accessible and personalized, as well as be cleared by the FDA as a medical device. This first submission to the FDA marks a momentous milestone for our team and sets the stage for future FDA filings," said John Mastrototaro, CEO of Movano Health.
August 3, 2023
Brad Scheckner brings more than two decades of experience across biopharmaceutical, diagnostic, and medical device companies, including field sales and leadership positions at Genzyme, Sanofi, Crescendo Bioscience, Flexion Therapeutics, and Electromedical Products International.
| |
August 3, 2023
“Each of these remarkable individuals has made incredible strides to advance health, uplift the nursing profession, and made a positive impact on improving the delivery of care. Interprofessional collaboration is key to finding innovative solutions to the most complex challenges in healthcare to ultimately improve quality and access,” said Academy Academy of Nursing President Kenneth R. White, PhD, RN, AGACNP, ACHPN, FACHE, FAAN. “It is truly an honor to induct them as Honorary Fellows into the Academy this year, during our golden anniversary.”
| |
|
August 4, 2023
IEM contributes nearly $90,000 in supplies for pediatric care, disaster response and training.
| |
August 4, 2023
The Evoke® System is the First SCS System to Demonstrate Cost-Dominance at Two Years Post-Implant.
August 4, 2023
Polycythemia vera (PV) is a cancer originating from a disease-initiating stem cell in the bone marrow resulting in a chronic increase of red blood cells, white blood cells, and platelets. PV may result in cardiovascular complications such as thrombosis and embolism, and often transforms to secondary myelofibrosis or leukemia. While the molecular mechanism underlying PV is still subject of intense research, current results point to a set of acquired mutations, the most important being a mutant form of JAK2
August 4, 2023
First and only AFib ablation products to receive approval for use in a workflow without fluoroscopy from the U.S. Food and Drug Administration. Enables workflows with zero fluoroscopy during catheter ablation procedures. The approval is based on data from REAL AF Registry, demonstrating value of real-world evidence
| |
Medical Device News Magazine
A Division of PTM Healthcare Marketing, Inc.
Website
| | | | | |